PRMT6 Antibody, mAb, Rabbit
PRMT6 Antibody, MAb, Rabbit

Western blot analysis of PRMT6 expression in (1) Jurkat cell lysate; (2) NIH/3T3 cell lysate; (3) C6 cell lysate.

PRMT6 Antibody, mAb, Rabbit

Arginine methyltransferase that can catalyze the formation of both omega-N monomethylarginine (MMA) and asymmetrical dimethylarginine (aDMA), with a strong preference for the formation of aDMA.Preferentially methylates arginyl residues present in a glycine and arginine-rich domain and displays preference for monomethylated substrates.
A04506
¥37,309.00

Ask us a question
Overview
Specificity This product is specific to PRMT6
Host Species Rabbit
Immunogen A synthesized peptide derived from human PRMT6
Species Reactivity Human; Mouse; Rat
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Western Blot 1:1000-1:2000

Properties
Form Liquid
Storage Buffer Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed.
Purification Affinity-chromatography
Isotype Rabbit IgG
Clonality Monoclonal

Examples
  • PRMT6 Antibody, MAb, Rabbit
    • PRMT6 Antibody, MAb, Rabbit

    Western blot analysis of PRMT6 expression in (1) Jurkat cell lysate; (2) NIH/3T3 cell lysate; (3) C6 cell lysate.


Background
Target Background Arginine methyltransferase that can catalyze the formation of both omega-N monomethylarginine (MMA) and asymmetrical dimethylarginine (aDMA), with a strong preference for the formation of aDMA.Preferentially methylates arginyl residues present in a glycine and arginine-rich domain and displays preference for monomethylated substrates.
Synonyms HRMT1L6; PRMT 6;

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.